PrimeRFP SCOUT · Federal Contract Profile

Dna Twopointo (G9S3SC8T5DM1)Federal contracts · 1 recompete

Dna Twopointo holds $225K in federal volume across 1 award actions, with 100% at Department of Health and Human Services (HHS). SCOUT tracks 1 incumbent recompete — an estimated $300K returning to market over the next 24 months (Low exposure). Primary work: Biological Product Manufacturing (100% prime). Obligations are roughly flat year over year.

$225K

Federal Volume

Recompetes (24mo)

HHS

Top Agency · 100% firm-wide

1

Award Actions

Choose one — this changes what we ask next

Score my firm against Dna Twopointo

Email me when a Dna Twopointo recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325414 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

Sole agency

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$225K · 100% of firm total

Mostly sole-source · 100%

100% of Dna Twopointo’s obligations are not openly competed — these contracts typically renew with the incumbent rather than going to recompete.

Part of the DNA TWOPOINTO INC corporate family · 2 entities

Metrics basis: local_db

Who buys from them

Agency buyer map

1 buyers

Department of Health and Human Services (HHS)3 awards · repeat buyer · $225K

Recompete exposure & trajectory

Recompete exposure

Low

Largely sole-source — these contracts typically renew with Dna Twopointo rather than being openly recompeted.

Dna Twopointo has an estimated $300K in contracts returning to market over the next 24 months.

YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY →

PIID: 75N93023P00594 · Expires 2028-05-13

$300K

Trajectory

▬ Steady0% YoYFY2025 vs FY2024

'24

'25

“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”

— Peter Lierni, Solutioneering

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Dna Twopointo hold?

Dna Twopointo (UEI G9S3SC8T5DM1) shows $225K across 1 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Dna Twopointo have?

Dna Twopointo shows $225K across 1 award actions. SCOUT tracks 1 incumbent recompetes ($300K) returning to market in the next 24 months.

Which agencies does Dna Twopointo work with?

Dna Twopointo’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).

What is the UEI for Dna Twopointo?

The Unique Entity ID (UEI) for Dna Twopointo is G9S3SC8T5DM1.

Does Dna Twopointo have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.